References
- Pouchedly C. Hyperuricemia in leukemia and lymphoma Part I. New York State Journal of Medicine; 1973, May, 1085–92.
- Groeger J. S. Critical Care of the Cancer Patient; 2nd edn. 1991; 155–58
- Sondheimer J. H., Migdal S. D. Toxic nephropathies. Critical Care Clinics 1987; 3(4)883–907
- Thomas C. R., Jr., Oodhia N. Common emergencies in cancer medicine: metabolic syndromes. Journal of' National Medical Association 1991; 83(9)809–18
- Stokes D. N. Tumor lysis syndrome and the anaesthesiologist: Intensive care aspects of paediatric oncology. Seminars In Surgical Oncology 1990; 6(3)156–61
- Eltinger D. S., Harker W. G., Gerry H. W., et al. Hyperphosphatemia, hypocalcemia and transient renal failure;. Journul of American Medical Association 1978; 239: 2472–74
- O'Conner L. R., Klein K. L., Bethune J. E. Hyperphosphatemia in lactic acidosis. New England Journal of Medicine 1977; 291: 707–9
- Editorial. Tumor lysis syndrome;. Lancet 1981; 849
- McCroskey R. D., Mosher D. F., Spencer C. D., Prendergrast E., Longo W. L. Acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high dose cytosine arabinoside, cisplatinum and etoposide. Cancer 1990; 66: 246–50
- Barton J. C. Tumor lysis syndrome in nonhematopoeitic neoplasms. Cancer 1989; 64: 738–40
- Hussein A. M., Feun L. G. Tumor lysis syndrome after induction chemotherapy in small-cell lung carcinoma. American Journal of Clinical Oncology 1990; 13(1)10–13
- Tomlinson G. C., Solberg L. A. Acute tumor lysis syndrome with metastatic medulloblastoma. Cancer 1984; 53: 1783–5
- Sparano J., Ramirez M., Wiernick P. H. Increasing recognition of corticosteroid induced tumor lysis syndrome in non-Hodgkins lymphoma. Cancer 1990; 65: 1072–75
- Cech P., Block J. B., Cone L. A., Tome R. Tumor lysis syndrome after tamoxifen flare. New England Journal of Medicine 1986; 315: 263–64
- Fer M. F., Bottin D. B., Sherwin S. A. Atypical tumor lysis syndrome in a patient with T-cell lymphoma treated with recombinant leukocyte interferon. American Journal of Medicine 1984; 11: 953–56
- Fleming D. R., Henslee-Downey J., Coffey C. Radiation induced tumor lysis syndrome in the bone marrow transplantation setting. Bone Marrow Transplantation 1991; 8: 235–6
- Schilsky R. L. Renal and metabolic toxicities of cancer treatment in toxicity of chemotherapy, M. C. Perry, J. W. Yarboro, 1984, eds.) Grune and Stratton, Orlando, Fla, 317–42.
- Anderson R. E., Williams W. L. Radiosensitivity of T & B lymphocytes. American Journal of Pathology 1987; 89: 367–78
- Tsokos G. C., Balow J. E., Spiegel R. J., et al. Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas. Medicine 1981; 60: 218–29
- Frei E., III, Bentzel C., Riesgelbach R., Block J. Renal complications of neoplastic disease. Journal of Chronic Disease 1963; 16: 757
- Band P. R., Silverberg D. S., Henderson J. F. Xanthine nephropathy in patients treated with allopurinol;. New England Journal of Medicine 1970; 382: 354–57
- Williams A. W., Wilson D. M. Uric acid metabolism in humans. Seminars in Nephrology 1990; 10: 9–14
- Pouchedly K. Hyperuricemia in leukemia and lymphoma Part II. New York State Journal of Medicine 1973, May, 1194–1200.
- Vaziri N. D., Ness R., Weillikson L. Bicarbonate buffered peritoneal dialysis: an effective adjunct in the treatment of lactic acidosis. American Journal of Medicine 1979; 67: 392
- Steinberg S. M., Galen M. A., Lazarus J. M., et al. Hemodialysis for acute anuric acid nephropathy. American Journal of Diseases of Childhood 1975; 129: 956–58
- Maher J., Roth C., Schreiner G. Hyperuricemia complicating leukemia; treatment with allopurinol and dialysis. Archive of Internal Medicine 1969; 123: 198
- Lloyd-Thomas A. R., Wright I., Lister I. A., Hinds C. J. Prognosis of patients receiving intensive care for life-threatening medical complications of haematological malignancy. British Medical Journal 1988; 296: 1029–9